1. Home
  2. KUKE vs GBIO Comparison

KUKE vs GBIO Comparison

Compare KUKE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KUKE
  • GBIO
  • Stock Information
  • Founded
  • KUKE 2002
  • GBIO 2016
  • Country
  • KUKE China
  • GBIO United States
  • Employees
  • KUKE N/A
  • GBIO N/A
  • Industry
  • KUKE Other Consumer Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KUKE Real Estate
  • GBIO Health Care
  • Exchange
  • KUKE Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • KUKE 42.0M
  • GBIO 41.2M
  • IPO Year
  • KUKE 2021
  • GBIO 2020
  • Fundamental
  • Price
  • KUKE $1.35
  • GBIO $6.11
  • Analyst Decision
  • KUKE
  • GBIO Buy
  • Analyst Count
  • KUKE 0
  • GBIO 4
  • Target Price
  • KUKE N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • KUKE 1.2M
  • GBIO 47.0K
  • Earning Date
  • KUKE 11-04-2025
  • GBIO 11-07-2025
  • Dividend Yield
  • KUKE N/A
  • GBIO N/A
  • EPS Growth
  • KUKE N/A
  • GBIO N/A
  • EPS
  • KUKE N/A
  • GBIO N/A
  • Revenue
  • KUKE $9,442,397.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • KUKE N/A
  • GBIO N/A
  • Revenue Next Year
  • KUKE N/A
  • GBIO N/A
  • P/E Ratio
  • KUKE N/A
  • GBIO N/A
  • Revenue Growth
  • KUKE N/A
  • GBIO 61.15
  • 52 Week Low
  • KUKE $0.52
  • GBIO $3.00
  • 52 Week High
  • KUKE $10.00
  • GBIO $25.70
  • Technical
  • Relative Strength Index (RSI)
  • KUKE 66.02
  • GBIO 51.08
  • Support Level
  • KUKE $0.54
  • GBIO $6.06
  • Resistance Level
  • KUKE $0.63
  • GBIO $6.47
  • Average True Range (ATR)
  • KUKE 0.11
  • GBIO 0.31
  • MACD
  • KUKE 0.10
  • GBIO -0.06
  • Stochastic Oscillator
  • KUKE 87.37
  • GBIO 19.79

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: